A carregar...

Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial

BACKGROUND: Liraglutide 3 mg was recently approved as an anti-obesity drug. Metformin is weight neutral, yet it could enhance the therapeutic index of GLP-1 agonist. We compared weight-lowering potential of liraglutide 1.2 mg in combination with metformin to liraglutide 3 mg monotherapy in obese PCO...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Endocr Disord
Main Authors: Jensterle, Mojca, Kravos, Nika Aleksandra, Goričar, Katja, Janez, Andrej
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5286837/
https://ncbi.nlm.nih.gov/pubmed/28143456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-017-0155-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!